Connecting to the community: How CCBHCs partnered with Owl Insights to deliver collaborative care
CEO, Owl Insights
Eric Meier has over 25 years of experience in the health care market place specifically in the development and commercialization of novel disruptive and innovative health care solutions. These solutions span software, medical devices, drug delivery, and drug compounds. He has built world class teams with deep domain knowledge in the areas of behavioral health, neuroscience, oncology, cardiovascular, and general surgery. He has extensive experience in fund raising from a variety of US, European, and Asian sources including institutional, family office, strategic, and non-profit entities. He has raised over $200 million to date and structured a variety of complex transactions.Mr. Meier has had extensive operating experience in both large and emerging companies.At Johnson and Johnson, he led a variety of corporate development activities focused upon identifying new markets, technologies, and company prospects at several operating companies.In 2000, Mr. Meier founded Calypso Medical and served as its President and CEO from 2000 - 2010, a medical device company providing real time tumor tracking company for the precise delivery of external beam radiation therapy. During that period, the company raised in excess of $175M, achieved five product clearances and treated in excess of 50,000 patients. In 2011, the company was acquired by Varian Medical Systems.In 2010, Mr. Meier joined Cervel Neurotech, a medical device company providing targeted non-invasive deep brain stimulation for psychiatric and neurologic disorders, as President and CEO. Since 2010, Cervel has completed a variety of successful clinical studies including a randomized sham controlled study for patients suffering from depression. The company has built a world class management team and raised in excess of $25M.Mr. Meier is a member of the board of directors of the Medical Device Manufacturers Association, Doernbecher Foundation, and Ziba Design.He is also an active angel investor.
Monique is an expert in delivering whole-person centered care. Powered by funding from SAMSHA, Monarch is focused on addressing mental health and substance use disorder treatment access; opioid crisis service expansion; primary care health screenings; expanded behavioral health support for veterans; and collaboration among community care partners. Monique is proud of what her team has achieved. Programs such as Medication-Assisted Treatment (MAT) which provides injections for individuals with substance use disorders, a family partner program, and a peer support program for the rapid opioid overdose team have had an impact within the community. She was able to expand clinical practice to include the use of standardized screening tools and integrating a new approach to providing care for people with co-occurring disorders which is a substance use disorder with a diagnosed mental health disorder The team at Monarch are looking forward to what they can accomplish in the coming two years as they intend to focus on building a peer recovery center, launching an intensive substance abuse outpatient treatment program, introducing an occupational therapy program and a peer bridge program to support individuals following a psychiatric hospital stay.
Join thousands of health plan executives, providers, investors, employers, technologists, and other digital health enthusiasts as we support BEAM advance emotional and mental health access for underserved populations.